Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay.
Naserke HE, Dozio N, Ziegler AG, Bonifacio E. Naserke HE, et al. Diabetologia. 1998 Jun;41(6):681-3. doi: 10.1007/s001250050968. Diabetologia. 1998. PMID: 9662050
Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects.
Hummel M, Bonifacio E, Naserke HE, Ziegler AG. Hummel M, et al. Among authors: naserke he. Diabetes Care. 2002 Jul;25(7):1111-6. doi: 10.2337/diacare.25.7.1111. Diabetes Care. 2002. PMID: 12087006 Clinical Trial.
Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.
Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ, Bonifacio E, Ziegler AG. Achenbach P, et al. Among authors: naserke he. Diabetes. 2004 Feb;53(2):384-92. doi: 10.2337/diabetes.53.2.384. Diabetes. 2004. PMID: 14747289 Free article.
Frequency of islet autoantibodies in relatives of patients with Type II diabetes or gestational diabetes.
Naserke HE, Schenker M, Ziegler AG. Naserke HE, et al. Diabetologia. 1999 Nov;42(11):1377. doi: 10.1007/s001250051454. Diabetologia. 1999. PMID: 10550425 No abstract available.
Reduced IL-4 associated antibody responses to vaccine in early pre-diabetes.
Schmid S, Molteni A, Füchtenbusch M, Naserke HE, Ziegler AG, Bonifacio E. Schmid S, et al. Among authors: naserke he. Diabetologia. 2002 May;45(5):677-85. doi: 10.1007/s00125-002-0816-7. Epub 2002 Apr 17. Diabetologia. 2002. PMID: 12107748
Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes.
Naserke HE, Bonifacio E, Ziegler AG. Naserke HE, et al. J Clin Endocrinol Metab. 2001 Oct;86(10):4826-33. doi: 10.1210/jcem.86.10.7931. J Clin Endocrinol Metab. 2001. PMID: 11600549
Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: sensitive early detection using a protein A/G-based radiobinding assay.
Naserke HE, Bonifacio E, Ziegler AG. Naserke HE, et al. J Clin Endocrinol Metab. 1999 Apr;84(4):1239-43. doi: 10.1210/jcem.84.4.5597. J Clin Endocrinol Metab. 1999. PMID: 10199761
Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE, Ziegler AG, Lampasona V, Bonifacio E. Naserke HE, et al. J Immunol. 1998 Dec 15;161(12):6963-9. J Immunol. 1998. PMID: 9862731 Free article.
The T-cell receptor beta chain CDR3 region of BV8S1/BJ1S5 transcripts in type 1 diabetes.
Naserke HE, Durinovic-Bellò I, Seidel D, Ziegler AG. Naserke HE, et al. Immunogenetics. 1996;45(2):87-96. doi: 10.1007/s002510050176. Immunogenetics. 1996. PMID: 8952958
Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes.
Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Achenbach P, et al. J Clin Invest. 2004 Aug;114(4):589-97. doi: 10.1172/JCI21307. J Clin Invest. 2004. PMID: 15314696 Free PMC article.